Laparoscopic visualisation of the ureters using near-infrared fluorescence imaging after retrograde indocyanine green injection in deep infiltrating endometriosis: the LAVIC trial
Archives of Gynecology and Obstetrics · 21.09.2026
DOI: 10.1007/s00404-026-08559-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 21.09.2026. Verfasst von Cloé Vaineau und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bern.
Abstract (Originalsprache)
Objective
To evaluate the feasibility and safety of intraureteral indocyanine green fluorescence for real-time ureter visualisation during laparoscopic surgery for deep infiltrating endometriosis. Materials and methods In this prospective, single-arm feasibility study, premenopausal women undergoing minimally invasive surgery for suspected deep infiltrating endometriosis received bilateral retrograde intraureteral indocyanine green following laparoscopic confirmation of the disease. Near-infrared fluorescence imaging was used for real-time ureteral visualisation. The primary outcome was the rate of successful ureteral visualisation. Secondary outcomes included fluorescence characteristics, the extent of ureterolysis, and procedure-related adverse events. Data were analysed primarily using descriptive statistics, with exploratory analyses performed where appropriate.
Results
Fifty-one patients with a mean age of 36 years were included. The mean duration of surgery was 217.3 ± 81.1 min. The mean duration of cystoscopy was 7.0 ± 5.0 min, and for intraureteral ICG injection 4.3 ± 3.3 min. Bilateral ureteral fluorescence was achieved in 50 of 51 patients (98%). Visualisation was immediate in all cases and persisted throughout surgery. Ureterolysis was required in 45% of patients. No ureteral injuries or ICG-related complications occurred.
Conclusion
Intraureteral ICG fluorescence appears feasible for real-time ureteral visualisation during complex surgery for deep infiltrating endometriosis. No adverse events attributable to intraureteral ICG administration were observed; however, its clinical utility requires further evaluation in comparative studies.
Trial registration
The trial protocol is registered at clinicaltrials.gov, NCT05206279
Förderung
- University of Bern
Zitieren
APA
Vaineau, C., Schlatter, B., Imboden, S., Villiger, A., Gulz, M., Mueller, M. D., & Siegenthaler, F. (2026). Laparoscopic visualisation of the ureters using near-infrared fluorescence imaging after retrograde indocyanine green injection in deep infiltrating endometriosis: the LAVIC trial. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-026-08559-0
Vancouver
Vaineau C, Schlatter B, Imboden S, Villiger A, Gulz M, Mueller MD, et al. Laparoscopic visualisation of the ureters using near-infrared fluorescence imaging after retrograde indocyanine green injection in deep infiltrating endometriosis: the LAVIC trial. Archives of Gynecology and Obstetrics. 2026. doi:10.1007/s00404-026-08559-0
BibTeX
@article{Vaineau2026,
author = {Vaineau, Cloé and Schlatter, Bettina and Imboden, Sara and Villiger, Anna-Sophie and Gulz, Marietta and Mueller, Michael D. and Siegenthaler, Franziska},
title = {Laparoscopic visualisation of the ureters using near-infrared fluorescence imaging after retrograde indocyanine green injection in deep infiltrating endometriosis: the LAVIC trial},
journal = {Archives of Gynecology and Obstetrics},
year = {2026},
doi = {10.1007/s00404-026-08559-0}
}
EUVIMED